UNHEALTHY DIET References

1.            Chasens ER. Obstructive sleep apnea, daytime sleepiness, and type 2 diabetes. Diabetes Educ 33: 475-482, 2007.

2.            Drummond S. Obesity: a diet that is acceptable is more likely to succeed. J Fam Health Care 17: 219-221, 2007.

3.         Gami AS, Caples SM, and Somers VK. Obesity and obstructive sleep apnea. Endocrinol Metab Clin North Am 32: 869-894, 2003.

4.            Gilbert PA, and Khokhar S. Changing dietary habits of ethnic groups in Europe and implications for health. Nutr Rev 66: 203-215, 2008.

5.            Harsch IA, Konturek PC, Koebnick C, Kuehnlein PP, Fuchs FS, Pour Schahin S, Wiest GH, Hahn EG, Lohmann T, and Ficker JH. Leptin and ghrelin levels in patients with obstructive sleep apnoea: effect of CPAP treatment. Eur Respir J 22: 251-257, 2003.

6.            James WP. The fundamental drivers of the obesity epidemic. Obes Rev 9 Suppl 1: 6-13, 2008.

7.         Klok MD, Jakobsdottir S, and Drent ML. The role of leptin and ghrelin in the regulation of food intake and body weight in humans: a review. Obes Rev 8: 21-34, 2007.

8.            Knutson KL, Spiegel K, Penev P, and Van Cauter E. The metabolic consequences of sleep deprivation. Sleep Med Rev 11: 163-178, 2007.

9.            McEwen BS. Sleep deprivation as a neurobiologic and physiologic stressor: Allostasis and allostatic load. Metabolism 55: S20-23, 2006.

10.       Ness-Abramof R, and Apovian CM. Drug-induced weight gain. Drugs Today (Barc) 41: 547-555, 2005.

11.       Penev PD. Sleep deprivation and energy metabolism: to sleep, perchance to eat? Curr Opin Endocrinol Diabetes Obes 14: 374-381, 2007.

12.            Piechota G, Malkiewicz J, and Karwat ID. [Obesity as a cause and result of disability]. Przegl Epidemiol 59: 155-161, 2005.

13.       Pijl H, and Meinders AE. Bodyweight change as an adverse effect of drug treatment. Mechanisms and management. Drug Saf 14: 329-342, 1996.

14.       Pillar G, and Shehadeh N. Abdominal fat and sleep apnea: the chicken or the egg? Diabetes Care 31 Suppl 2: S303-309, 2008.

15.            Popovic V, and Duntas LH. Brain somatic cross-talk: ghrelin, leptin and ultimate challengers of obesity. Nutr Neurosci 8: 1-5, 2005.

16.            Saaresranta T, and Polo O. Does leptin link sleep loss and breathing disturbances with major public diseases? Ann Med 36: 172-183, 2004.

17.            Spiegel K, Knutson K, Leproult R, Tasali E, and Van Cauter E. Sleep loss: a novel risk factor for insulin resistance and Type 2 diabetes. J Appl Physiol 99: 2008-2019, 2005.

18.            Steinberg GR. Inflammation in obesity is the common link between defects in fatty acid metabolism and insulin resistance. Cell Cycle 6: 888-894, 2007.

19.            Trenell MI, Marshall NS, and Rogers NL. Sleep and metabolic control: waking to a problem? Clin Exp Pharmacol Physiol 34: 1-9, 2007.

20.            Varela-Moreiras G. Controlling obesity: what should be changed? Int J Vitam Nutr Res 76: 262-268, 2006.

21.            Williams DL, and Cummings DE. Regulation of ghrelin in physiologic and pathophysiologic states. J Nutr 135: 1320-1325, 2005.